Tivantinib™ is designed to block the activity of c-MET, a molecule that plays multiple key roles in human cancer including cancer cell growth,survival, angiogenesis, invasion and metastasis in nsNSCLC (non squamous Non-Small Cell Lung Cancer).
Keywords: Airbrush, Color, 3D, Advertising / Marketing, Biotechnology, Cell biology / Histology, Disease Management, Pharmacology, Respiratory, Oncology
© Cynthia Turner